Your browser doesn't support javascript.
loading
Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy.
Puolakkainen, Tero; Ma, Hongqian; Kainulainen, Heikki; Pasternack, Arja; Rantalainen, Timo; Ritvos, Olli; Heikinheimo, Kristiina; Hulmi, Juha J; Kiviranta, Riku.
Afiliação
  • Puolakkainen T; Department of Medical Biochemistry and Genetics, University of Turku, Kiinamyllynkatu 10, FI-20520, Turku, Finland.
  • Ma H; Department of Biology of Physical Activity, University of Jyväskylä, Jyväskylä, Finland.
  • Kainulainen H; Institute of Dentistry, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Pasternack A; Department of Biology of Physical Activity, University of Jyväskylä, Jyväskylä, Finland.
  • Rantalainen T; Department of Physiology, University of Helsinki, Helsinki, Finland.
  • Ritvos O; Centre for Physical Activity and Nutrition Research, Deakin University, Melbourne, Australia.
  • Heikinheimo K; Department of Physiology, University of Helsinki, Helsinki, Finland.
  • Hulmi JJ; Department of Oral and Maxillofacial Surgery, Institute of Dentistry, University of Turku, Turku, Finland.
  • Kiviranta R; Department of Oral Diagnostic Sciences, Institute of Dentistry, University of Eastern Finland, Kuopio, Finland.
BMC Musculoskelet Disord ; 18(1): 20, 2017 01 19.
Article em En | MEDLINE | ID: mdl-28103859
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Densidade Óssea / Distrofia Muscular de Duchenne / Receptores de Activinas Tipo II / Distrofia Muscular Animal Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Densidade Óssea / Distrofia Muscular de Duchenne / Receptores de Activinas Tipo II / Distrofia Muscular Animal Idioma: En Ano de publicação: 2017 Tipo de documento: Article